GL1X · GenesisL1 explorer

Research workbench

The interaction of CHLORIDO(1,5-CYCLOOCTADIENE)([4-(2-((tert- BUTOXYCARBONYL)AMINO)-3-methoxy-3-oxopropyl)-1,3-dimethyl-1H- imidazol-3-IDE])RHODIUM(I) with hewl after 1 month

Analyse The interaction of CHLORIDO(1,5-CYCLOOCTADIENE)([4-(2-((tert… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6WRM
Type
protein
Length
129 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Lysozyme
EC
3.2.1.17
UniProt
B8YK79
Ligands
U8G, NA, RH, CL
Pockets
1 · best druggability 0.32

Structure

x-ray diffraction · 1 distinct chain · 41% helix, 11% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ALysozyme (EC 3.2.1.17)protein12941% helix, 11% strandB8YK79

Ligands and binding sites

  • U8G · (4-{2-[(tert-butoxycarbonyl)amino]-3-methoxy-3-oxopropyl}-1,3-dimethyl-2,3-dihydro-1H-imidazol-2-yl) rhodium · ligand · chains A
  • NA · Sodium ion · metal · chains A
  • RH · Rhodium · metal · chains A
  • CL · Chloride ion · ion · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1710.320.7516empty

Modifications

Observed in the structure: 4 disulfide (disulfide).

Compared structures

  • 6WRM · The interaction of chlorido(1,5-cyclooctadiene)([4-(2-((tert-butoxycarbonyl)amino)-3-metho… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.